Assessing EGFR Mutations
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Rare EGFR mutations may include artifactual mutations generated during the pre-analytic period.
“Importantly, rare mutations may include artifactual mutations that are generated during the pre‐analytic period.22”
From Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategy (2016) · cites this paper as [22]
Cites
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
Tsao, M., Sakurada, A., Cutz, J.-C., Zhu, C., Kamel‐Reid, S., Squire, J. A., Lorimer, I. A. J., Zhang, T., Liu, G., Daneshmand, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050736 · Cited by 1,815 · see citing works
Hofreiter, M. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.23.4793 · Cited by 684 · see citing works
A High Frequency of Sequence Alterations Is Due to Formalin Fixation of Archival Specimens
Williams, C., Pontén, F., Moberg, C., Söderkvist, P., Uhlén, M., Pontén, J., Sitbon, G., & Lundeberg, J. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65461-2 · Cited by 514 · see citing works
Somatic Mutations of Epidermal Growth Factor Receptor in Colorectal Carcinoma
Nagahara, H., Mimori, K., Ohta, M., Utsunomiya, T., Inoue, H., Barnard, G. F., Ohira, M., Hirakawa, K., & Mori, M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1894 · Cited by 125 · see citing works
Akbari, M., Hansen, M. D., Halgunset, J., et al. (2005) · Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60006-2 · Cited by 105 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Mitsudomi, T., & Yatabe, Y. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00607.x · Cited by 606 · see citing works
Kobayashi, Y., & Mitsudomi, T. (2016) · Cancer Science · doi:10.1111/cas.12996 · Cited by 413 · see citing works
Kancha, R. K., von Bubnoff, N., Peschel, C., & Duyster, J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1757 · Cited by 168 · see citing works
De Pas, T., Toffalorio, F., Manzotti, M., Fumagalli, C., Spitaleri, G., Catania, C., Delmonte, A., Giovannini, M., Spaggiari, L., de Braud, F., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318227e8c6 · Cited by 138 · see citing works
Peng, L., Song, Z.-G., & Jiao, S.-C. (2014) · Scientific Reports · doi:10.1038/srep06104 · Cited by 48 · see citing works
Pang, B., Matthias, D., Ong, C. W., Dhewar, A. N., Gupta, S., Lim, G. L., Nga, M. E., Seet, J. E., Qasim, A., Chin, T. M., et al. (2012) · Cytopathology · doi:10.1111/j.1365-2303.2012.01000.x · Cited by 47 · see citing works
- Authors
- Marchetti, A., Felicioni, L., & Buttitta, F.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-02-02
- Volume
- 354
- Issue
- 5
- Pages
- 526-528
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W152953340
- Cited by
- 189
- References
- 5
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 3 · 2019: 5 · 2018: 6 · 2017: 7 · 2016: 8 · 2015: 11 · 2014: 11 · 2013: 10 · 2012: 18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
- Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- EGFR mutation, epidermal growth factor receptor, lung cancer, molecular testing, targeted therapy
- MeSH terms
- Erlotinib Hydrochloride, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, DNA Mutational Analysis, Humans, Lung Neoplasms, Mutation, Quinazolines, Survival Analysis, Polymerase Chain Reaction, Paraffin Embedding, Sequence Deletion, Protein Kinase Inhibitors, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
